Observing the effects of acetylaconitine tablets on chronic pain
Real-World Registry Study on Clinical Analgesic Effect of Acetylaconitine Tablets
This study is testing if acetylaconitine tablets can help people with chronic pain feel better and what side effects they might have.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3500 (estimated) |
| Sex | All |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Trial ID | NCT05687929 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the clinical analgesic effects, safety, and adverse reactions associated with acetylaconitine tablets in patients suffering from chronic pain. Participants will be monitored through a series of follow-up visits over a 12-week period, including outpatient, telephone, and app-based follow-ups. The study will also analyze the main factors influencing the effectiveness of the treatment. Patients will be required to provide informed consent before participating.
Who should consider this trial
Good fit: Ideal candidates for this study are patients experiencing chronic pain for more than one month with a pain intensity score greater than 40 mm on the Visual Analog Scale.
Not a fit: Patients who are unable to communicate, have allergies to acetylaconitine, or have previously taken acetylaconitine drugs may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for patients suffering from chronic pain.
How similar studies have performed: While this study focuses on acetylaconitine, similar observational studies have shown promise in evaluating real-world effectiveness of analgesics, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with chronic pain \> 1 month and VAS \> 40 mm Patients who can take the acetylaconitine tablets orally Exclusion Criteria: * Patients who cannot communicate or receive follow-up Patients allergic to acetylaconitine Patients who have taken the acetylaconitine drugs orally
Where this trial is running
Changsha, Hunan
- The Third Xiangya Hospital of Central South University — Changsha, Hunan, China (Recruiting)
Study contacts
- Study coordinator: Ma Ke, doctor
- Email: marke72@163.com
- Phone: 13361879260
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.